Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks

200390 citationsJournal Article

Authors

Good health and well-being

Published in: Investigational New Drugs

Volume 21, Issue 1, pp. 85-97

Field-Weighted Citation Impact: 2.04